Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Buy
60
EMR Quote, Financials, Valuation and Earnings
Last price:
$111.78
Seasonality move
:
3.99%
Day range:
$111.41 - $114.32
52-week range:
$96.62 - $134.85
Dividend yield:
1.85%
P/E ratio:
27.11x
P/S ratio:
3.71x
P/B ratio:
3.13x
Volume:
2.6M
Avg. volume:
2.9M
1-year change:
2.71%
Market cap:
$64.1B
Revenue:
$17.5B
EPS (TTM):
$4.19
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $16.8B | $12.9B | $13.8B | $15.2B | $17.5B | |
| Revenue Growth (YoY) | -8.64% | -22.96% | 6.74% | 9.86% | 15.35% | |
| Cost of Revenues | $9.8B | $7.2B | $7.5B | $7.7B | $8.6B | |
| Gross Profit | $7B | $5.7B | $6.3B | $7.4B | $8.9B | |
| Gross Profit Margin | 41.76% | 44.31% | 45.68% | 48.98% | 50.8% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4B | $3.5B | $3.6B | $4.2B | $5.1B | |
| Other Inc / (Exp) | -$293M | -$42M | $270M | $137M | -$557M | |
| Operating Expenses | $4.2B | $3.8B | $4B | $4.7B | $6.2B | |
| Operating Income | $2.8B | $2B | $2.4B | $2.8B | $2.7B | |
| Net Interest Expenses | $156M | $155M | $194M | -- | $89M | |
| EBT. Incl. Unusual Items | $2.3B | $1.8B | $2.4B | $2.9B | $2B | |
| Earnings of Discontinued Ops. | -- | $911M | $1.3B | $10.9B | $350M | |
| Income Tax Expense | $345M | $346M | $549M | $642M | $415M | |
| Net Income to Company | $2B | $1.4B | $1.9B | $2.3B | $1.6B | |
| Minority Interest in Earnings | -$25M | -$24M | $1M | $19M | $13M | |
| Net Income to Common Excl Extra Items | $2B | $2.3B | $3.2B | $13.2B | $2B | |
| Basic EPS (Cont. Ops) | $3.26 | $3.85 | $5.44 | $23.00 | $3.44 | |
| Diluted EPS (Cont. Ops) | $3.24 | $3.82 | $5.41 | $22.88 | $3.43 | |
| Weighted Average Basic Share | $602.9M | $598.1M | $592.9M | $574.2M | $571.3M | |
| Weighted Average Diluted Share | $606.6M | $601.8M | $596.3M | $577.3M | $574M | |
| EBITDA | $3.4B | $2.7B | $3.5B | $4.2B | $4B | |
| EBIT | $2.5B | $1.9B | $2.7B | $3.2B | $2.3B | |
| Revenue (Reported) | $16.8B | $12.9B | $13.8B | $15.2B | $17.5B | |
| Operating Income (Reported) | $2.8B | $2B | $2.4B | $2.8B | $2.7B | |
| Operating Income (Adjusted) | $2.5B | $1.9B | $2.7B | $3.2B | $2.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.2B | $3.2B | $3.4B | $4.1B | $4.2B | |
| Revenue Growth (YoY) | 0.24% | -24.15% | 6.88% | 22.06% | 1.41% | |
| Cost of Revenues | $2.4B | $1.7B | $1.8B | $2.2B | $1.9B | |
| Gross Profit | $1.7B | $1.4B | $1.6B | $1.9B | $2.2B | |
| Gross Profit Margin | 41.41% | 44.84% | 48.03% | 46.54% | 53.53% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $998M | $849M | $1B | $1.3B | $1.2B | |
| Other Inc / (Exp) | -$44M | $446M | -$2M | -$177M | $1M | |
| Operating Expenses | $1.1B | $880M | $1.1B | $1.6B | $1.5B | |
| Operating Income | $647M | $535M | $472M | $365M | $782M | |
| Net Interest Expenses | $40M | $39M | $48M | $13M | $8M | |
| EBT. Incl. Unusual Items | $563M | $942M | $422M | $175M | $775M | |
| Earnings of Discontinued Ops. | -- | $149M | $2B | -$27M | -- | |
| Income Tax Expense | $111M | $196M | $98M | $16M | $182M | |
| Net Income to Company | $452M | $746M | $324M | $159M | $593M | |
| Minority Interest in Earnings | -$7M | $1M | $5M | $10M | -$8M | |
| Net Income to Common Excl Extra Items | $445M | $896M | $2.3B | $142M | $585M | |
| Basic EPS (Cont. Ops) | $0.74 | $1.51 | $3.99 | $0.25 | $1.03 | |
| Diluted EPS (Cont. Ops) | $0.74 | $1.50 | $3.97 | $0.25 | $1.02 | |
| Weighted Average Basic Share | $598.5M | $594.6M | $583.6M | $570.8M | $568.5M | |
| Weighted Average Diluted Share | $601.9M | $598.1M | $586.7M | $573.3M | $571.1M | |
| EBITDA | $849M | $1.2B | $750M | $681M | $1.2B | |
| EBIT | $605M | $984M | $490M | $259M | $827M | |
| Revenue (Reported) | $4.2B | $3.2B | $3.4B | $4.1B | $4.2B | |
| Operating Income (Reported) | $647M | $535M | $472M | $365M | $782M | |
| Operating Income (Adjusted) | $605M | $984M | $490M | $259M | $827M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $16.8B | $11.9B | $14B | $15.9B | $17.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $9.8B | $6.5B | $7.5B | $8.2B | $8.3B | |
| Gross Profit | $7B | $5.4B | $6.5B | $7.7B | $9.2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.8B | $3.3B | $3.8B | $4.4B | $5.1B | |
| Other Inc / (Exp) | -$240M | $448M | -$204M | -$38M | -$438M | |
| Operating Expenses | $4.1B | $3.6B | $4.2B | $5.1B | $6.1B | |
| Operating Income | $2.9B | $1.8B | $2.3B | $2.7B | $3.1B | |
| Net Interest Expenses | $161M | $154M | $203M | -- | $84M | |
| EBT. Incl. Unusual Items | $2.5B | $2.1B | $1.9B | $2.7B | $2.6B | |
| Earnings of Discontinued Ops. | -- | $149M | $3.2B | $8.9B | $423M | |
| Income Tax Expense | $362M | $431M | $451M | $560M | $568M | |
| Net Income to Company | $2.1B | $1.7B | $1.5B | $2.1B | $2B | |
| Minority Interest in Earnings | -$29M | -$16M | $5M | $24M | -$5M | |
| Net Income to Common Excl Extra Items | $2.1B | $2.8B | $4.7B | $11B | $2.4B | |
| Basic EPS (Cont. Ops) | $3.47 | $4.62 | $7.92 | $19.30 | $4.23 | |
| Diluted EPS (Cont. Ops) | $3.45 | $4.58 | $7.88 | $19.20 | $4.19 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $3.5B | $3B | $3.1B | $4.2B | $4.6B | |
| EBIT | $2.7B | $2.3B | $2.2B | $3B | $2.9B | |
| Revenue (Reported) | $16.8B | $11.9B | $14B | $15.9B | $17.6B | |
| Operating Income (Reported) | $2.9B | $1.8B | $2.3B | $2.7B | $3.1B | |
| Operating Income (Adjusted) | $2.7B | $2.3B | $2.2B | $3B | $2.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.2B | $3.2B | $3.4B | $4.1B | $4.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.4B | $1.7B | $1.8B | $2.2B | $1.9B | |
| Gross Profit | $1.7B | $1.4B | $1.6B | $1.9B | $2.2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $998M | $849M | $1B | $1.3B | $1.2B | |
| Other Inc / (Exp) | -$44M | $446M | -$2M | -$177M | $1M | |
| Operating Expenses | $1.1B | $880M | $1.1B | $1.6B | $1.5B | |
| Operating Income | $647M | $535M | $472M | $365M | $782M | |
| Net Interest Expenses | $40M | $39M | $48M | $13M | $8M | |
| EBT. Incl. Unusual Items | $563M | $942M | $422M | $175M | $775M | |
| Earnings of Discontinued Ops. | -- | $149M | $2B | -$27M | -- | |
| Income Tax Expense | $111M | $196M | $98M | $16M | $182M | |
| Net Income to Company | $452M | $746M | $324M | $159M | $593M | |
| Minority Interest in Earnings | -$7M | $1M | $5M | $10M | -$8M | |
| Net Income to Common Excl Extra Items | $445M | $896M | $2.3B | $142M | $585M | |
| Basic EPS (Cont. Ops) | $0.74 | $1.51 | $3.99 | $0.25 | $1.03 | |
| Diluted EPS (Cont. Ops) | $0.74 | $1.50 | $3.97 | $0.25 | $1.02 | |
| Weighted Average Basic Share | $598.5M | $594.6M | $583.6M | $570.8M | $568.5M | |
| Weighted Average Diluted Share | $601.9M | $598.1M | $586.7M | $573.3M | $571.1M | |
| EBITDA | $849M | $1.2B | $750M | $681M | $1.2B | |
| EBIT | $605M | $984M | $490M | $259M | $827M | |
| Revenue (Reported) | $4.2B | $3.2B | $3.4B | $4.1B | $4.2B | |
| Operating Income (Reported) | $647M | $535M | $472M | $365M | $782M | |
| Operating Income (Adjusted) | $605M | $984M | $490M | $259M | $827M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.3B | $2.4B | $1.8B | $8.1B | $3.6B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.8B | $3B | $2.3B | $2.5B | $2.9B | |
| Inventory | $1.9B | $2.1B | $1.7B | $2B | $2.2B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $761M | $1.1B | $1.3B | $1.2B | $1.5B | |
| Total Current Assets | $8.8B | $8.4B | $8.5B | $13.8B | $10.2B | |
| Property Plant And Equipment | $3.7B | $3.7B | $2.2B | $2.4B | $2.8B | |
| Long-Term Investments | -- | -- | -- | $3.3B | -- | |
| Goodwill | $6.7B | $7.7B | $13.9B | $14.5B | $18.1B | |
| Other Intangibles | $2.5B | $2.9B | $6.6B | $6.3B | $10.4B | |
| Other Long-Term Assets | $1.2B | $1.9B | $4.4B | $2.6B | $2.7B | |
| Total Assets | $22.9B | $24.7B | $35.7B | $42.7B | $44.2B | |
| Accounts Payable | $1.7B | $2.1B | $1.3B | $1.3B | $1.3B | |
| Accrued Expenses | $2.9B | $3.3B | $3B | $3.2B | $3.9B | |
| Current Portion Of Long-Term Debt | $322M | $538M | $516M | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | $1.3B | -- | -- | |
| Total Current Liabilities | $5.8B | $6.2B | $7.8B | $5B | $5.7B | |
| Long-Term Debt | $6.3B | $5.8B | $8.3B | $7.6B | $7.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $14.4B | $14.8B | $19.4B | $16.1B | $16.7B | |
| Common Stock | $477M | $477M | $477M | $477M | $477M | |
| Other Common Equity Adj | -- | -- | -$1.5B | -$1.3B | -$868M | |
| Common Equity | $8.4B | $9.9B | $10.4B | $20.7B | $21.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $42M | $40M | $6B | $5.9B | $5.9B | |
| Total Equity | $8.4B | $9.9B | $16.3B | $26.6B | $27.5B | |
| Total Liabilities and Equity | $22.9B | $24.7B | $35.7B | $42.7B | $44.2B | |
| Cash and Short Terms | $3.3B | $2.4B | $1.8B | $8.1B | $3.6B | |
| Total Debt | $7.5B | $6.7B | $10.4B | $8.2B | $7.7B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.2B | $4.7B | $2.3B | $2.1B | $2.8B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.7B | $2.7B | $2.2B | $2.8B | $2.7B | |
| Inventory | $2B | $2.3B | $2B | $2.4B | $2.2B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $819M | $1.1B | $1.3B | $1.4B | $1.5B | |
| Total Current Assets | $7.7B | $10.9B | $9B | $8.7B | $9.2B | |
| Property Plant And Equipment | $4.2B | $4.2B | $2.7B | $3.3B | $2.7B | |
| Long-Term Investments | -- | -- | -- | $3.3B | -- | |
| Goodwill | $7.8B | $7.7B | $14.1B | $18B | $17.9B | |
| Other Intangibles | $3.2B | $2.8B | $6.5B | $11.3B | $10B | |
| Other Long-Term Assets | $220M | $158M | $2.4B | $227M | $2.7B | |
| Total Assets | $23.7B | $27B | $36.2B | $46.5B | $42.6B | |
| Accounts Payable | $1.7B | $2.1B | $1.2B | $1.2B | $1.3B | |
| Accrued Expenses | $1.5B | $1.6B | $1.4B | $1.2B | $3.6B | |
| Current Portion Of Long-Term Debt | $1.7B | $37M | $1.8B | $3.2B | -- | |
| Current Portion Of Capital Lease Obligations | $152M | $152M | $131M | $157M | -- | |
| Other Current Liabilities | -- | -- | $1.2B | -- | -- | |
| Total Current Liabilities | $6.4B | $5.3B | $8.2B | $7.8B | $6B | |
| Long-Term Debt | $5.9B | $8.7B | $8.2B | $7.6B | $6.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $14.7B | $16.7B | $19.5B | $20B | $16.2B | |
| Common Stock | $477M | $477M | $477M | $477M | $477M | |
| Other Common Equity Adj | -- | -- | -- | -$1.1B | -$1.3B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $44M | $39M | $6B | $5.9B | $5.9B | |
| Total Equity | $8.9B | $10.3B | $16.7B | $26.6B | $26.4B | |
| Total Liabilities and Equity | $23.7B | $27B | $36.2B | $46.5B | $42.6B | |
| Cash and Short Terms | $2.2B | $4.7B | $2.3B | $2.1B | $2.8B | |
| Total Debt | $7.6B | $8.8B | $10B | $10.9B | $7.6B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2B | $1.4B | $1.9B | $2.3B | $1.6B | |
| Depreciation & Amoritzation | $854M | $762M | $842M | $1.1B | $1.7B | |
| Stock-Based Compensation | $110M | $197M | $125M | $250M | $260M | |
| Change in Accounts Receivable | $207M | -$18M | -$143M | -$191M | -$99M | |
| Change in Inventories | -$6M | -$11M | -$334M | -$160M | $122M | |
| Cash From Operations | $3.1B | $3.6B | $2.9B | $637M | $3.3B | |
| Capital Expenditures | $538M | $404M | $299M | $363M | $419M | |
| Cash Acquisitions | -$126M | -$1.6B | -$5.7B | -$705M | -$8.3B | |
| Cash From Investing | -$740M | -$2.1B | -$5.3B | $12.4B | -$5.4B | |
| Dividends Paid (Ex Special Dividend) | -$1.2B | -$1.2B | -$1.2B | -$1.2B | -$1.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.3B | $71M | $5.4B | $395M | $322M | |
| Long-Term Debt Repaid | -$1.6B | -$883M | -$1.7B | -$3.6B | -$889M | |
| Repurchase of Common Stock | -$942M | -$500M | -$500M | -$2.2B | -$643M | |
| Other Financing Activities | $2M | $100M | $80M | -$169M | -$44M | |
| Cash From Financing | -$509M | -$2.4B | $2B | -$6.8B | -$2.5B | |
| Beginning Cash (CF) | $1.5B | $3.3B | $2.4B | $1.8B | $8.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.8B | -$967M | -$364M | $6.2B | -$4.5B | |
| Ending Cash (CF) | $3.3B | $2.4B | $1.8B | $8.1B | $3.6B | |
| Levered Free Cash Flow | $2.5B | $3.2B | $2.6B | $274M | $2.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $452M | $746M | $324M | $159M | $593M | |
| Depreciation & Amoritzation | $244M | $178M | $260M | $422M | $383M | |
| Stock-Based Compensation | $64M | $34M | $102M | $74M | $68M | |
| Change in Accounts Receivable | $232M | $172M | $78M | $94M | $156M | |
| Change in Inventories | -$37M | -$177M | -$193M | -$97M | -$86M | |
| Cash From Operations | $808M | $523M | $418M | $415M | $777M | |
| Capital Expenditures | $122M | $73M | $59M | $77M | $83M | |
| Cash Acquisitions | -$1.6B | $399M | $15M | -$8.3B | -$37M | |
| Cash From Investing | -$1.7B | $285M | $2.9B | -$8.5B | -$142M | |
| Dividends Paid (Ex Special Dividend) | -$303M | -$307M | -$306M | -$300M | -$301M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $3B | -- | -- | -- | |
| Long-Term Debt Repaid | -$301M | -$501M | -$9M | -- | -$2M | |
| Repurchase of Common Stock | -$13M | -$253M | -$2B | -$247M | -$899M | |
| Other Financing Activities | $42M | $22M | -$41M | -$45M | -$91M | |
| Cash From Financing | -$235M | $1.6B | -$2.9B | $2.1B | -$1.3B | |
| Beginning Cash (CF) | $3.3B | $2.4B | $1.8B | $8.1B | $3.6B | |
| Foreign Exchange Rate Adjustment | $29M | -$37M | $58M | $7M | -$98M | |
| Additions / Reductions | -$1.1B | $2.4B | $409M | -$6B | -$656M | |
| Ending Cash (CF) | $2.2B | $4.7B | $2.3B | $2.1B | $2.8B | |
| Levered Free Cash Flow | $686M | $450M | $359M | $338M | $694M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.1B | $1.7B | $1.5B | $2.1B | $2B | |
| Depreciation & Amoritzation | $887M | $696M | $924M | $1.2B | $1.7B | |
| Stock-Based Compensation | $118M | $167M | $193M | $222M | $254M | |
| Change in Accounts Receivable | $158M | -$78M | -$237M | -$175M | -$37M | |
| Change in Inventories | $124M | -$151M | -$350M | -$64M | $133M | |
| Cash From Operations | $3.5B | $3.3B | $2.8B | $634M | $3.7B | |
| Capital Expenditures | $546M | $355M | $285M | $381M | $425M | |
| Cash Acquisitions | -$1.7B | $448M | -$6.1B | -$9.1B | -$40M | |
| Cash From Investing | -$2.3B | -$115M | -$2.7B | $1.1B | $3B | |
| Dividends Paid (Ex Special Dividend) | -$1.2B | -$1.2B | -$1.2B | -$1.2B | -$1.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.5B | $3B | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.4B | -$1.1B | -$1.2B | -$3.6B | -$891M | |
| Repurchase of Common Stock | -$826M | -$740M | -$2.2B | -$461M | -$1.3B | |
| Other Financing Activities | $24M | $80M | $17M | -$173M | -$90M | |
| Cash From Financing | -$582M | -$586M | -$2.4B | -$1.9B | -$5.8B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $556M | $2.6B | -$2.4B | -$162M | $843M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2.9B | $2.9B | $2.5B | $253M | $3.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $452M | $746M | $324M | $159M | $593M | |
| Depreciation & Amoritzation | $244M | $178M | $260M | $422M | $383M | |
| Stock-Based Compensation | $64M | $34M | $102M | $74M | $68M | |
| Change in Accounts Receivable | $232M | $172M | $78M | $94M | $156M | |
| Change in Inventories | -$37M | -$177M | -$193M | -$97M | -$86M | |
| Cash From Operations | $808M | $523M | $418M | $415M | $777M | |
| Capital Expenditures | $122M | $73M | $59M | $77M | $83M | |
| Cash Acquisitions | -$1.6B | $399M | $15M | -$8.3B | -$37M | |
| Cash From Investing | -$1.7B | $285M | $2.9B | -$8.5B | -$142M | |
| Dividends Paid (Ex Special Dividend) | -$303M | -$307M | -$306M | -$300M | -$301M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $3B | -- | -- | -- | |
| Long-Term Debt Repaid | -$301M | -$501M | -$9M | -- | -$2M | |
| Repurchase of Common Stock | -$13M | -$253M | -$2B | -$247M | -$899M | |
| Other Financing Activities | $42M | $22M | -$41M | -$45M | -$91M | |
| Cash From Financing | -$235M | $1.6B | -$2.9B | $2.1B | -$1.3B | |
| Beginning Cash (CF) | $3.3B | $2.4B | $1.8B | $8.1B | $3.6B | |
| Foreign Exchange Rate Adjustment | $29M | -$37M | $58M | $7M | -$98M | |
| Additions / Reductions | -$1.1B | $2.4B | $409M | -$6B | -$656M | |
| Ending Cash (CF) | $2.2B | $4.7B | $2.3B | $2.1B | $2.8B | |
| Levered Free Cash Flow | $686M | $450M | $359M | $338M | $694M | |
Get EMR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
EMR
Sector
P/E ratio
27.11x
17.50x
PEG ratio
0.04x
0.28x
P/B ratio
3.13x
1.67x
Price / LTM sales
3.71x
0.90x
Growth Metrics
EMR
Sector
Revenue growth
1.41%
3.01%
Earnings growth
308%
6.36%
Revenue (5-year growth)
-0.98%
4.39%
Earnings forecast
$1.28
$0.36
Profitability
EMR
Sector
Profitability FY 2024
$8.9B
$412.5M
Return on invested capital
6.66%
5.68%
Return on assets
5.35%
3.57%
Return on equity
9%
8.64%
Earnings Date
Last Earnings Date
Feb
5
Next Earnings Date
May
8
Estimated Next Earnings Date
May
7
Balance Sheet
EMR
Sector
Total cash
$2.8B
$161.8M
Short term investments
--
$42.6M
Total assets
$44.2B
$1.9B
Long term debt
$7.6B
$267.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
